Replicel Life Sciences Inc
XTSX:RP

Watchlist Manager
Replicel Life Sciences Inc Logo
Replicel Life Sciences Inc
XTSX:RP
Watchlist
Price: 0.015 CAD 50% Market Closed
Market Cap: 722.3k CAD

Relative Value

RP doesn't have a meaningful market cap.

There is not enough data to reliably calculate the relative value of RP.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

RP Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
67
Median 3Y
0
Median 5Y
11.6
Industry
4
vs History
vs Industry
Median 3Y
-22
Median 5Y
-19.7
Industry
31.9
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-4.7
Industry
19.6
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-4.7
Industry
26.9
vs History
7
vs Industry
Median 3Y
1.5
Median 5Y
-0.6
Industry
2.8
vs History
vs Industry
63
Median 3Y
0
Median 5Y
10.5
Industry
4
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
8.9
vs History
vs Industry
Median 3Y
-6.9
Median 5Y
-7
Industry
18.9
vs History
vs Industry
Median 3Y
-6.9
Median 5Y
-7
Industry
24.1
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-4.6
Industry
20.3
vs History
vs Industry
Median 3Y
-2.4
Median 5Y
-4.6
Industry
26.9
vs History
vs Industry
Median 3Y
-39.2
Median 5Y
-30.3
Industry
2.3

Multiples Across Competitors

RP Competitors Multiples
Replicel Life Sciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Replicel Life Sciences Inc
XTSX:RP
722.3k CAD 0 -22 -12.5 -12.5
US
PerkinElmer Inc
LSE:0KHE
1.1T USD 382.2 4 527.2 1 327.9 2 667.7
US
Thermo Fisher Scientific Inc
NYSE:TMO
227.9B USD 5.3 35.1 24.6 31.8
US
Danaher Corp
NYSE:DHR
164.7B USD 6.8 47 25.2 38.1
CH
Lonza Group AG
SIX:LONN
35.9B CHF 5.1 48.9 37.4 37.4
US
Agilent Technologies Inc
NYSE:A
39.9B USD 5.7 30.6 23.6 28.2
US
IQVIA Holdings Inc
NYSE:IQV
40B USD 2.5 31.1 15 22.5
CN
WuXi AppTec Co Ltd
SSE:603259
270.5B CNY 6.1 18 20.6 20.6
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW 8.4 29 16.9 22.5
US
Mettler-Toledo International Inc
NYSE:MTD
29.4B USD 7.5 35.2 25.3 28.1
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.6B EUR 7 77.9 27.7 45.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Replicel Life Sciences Inc
XTSX:RP
Average EV/EBITDA: 154.4
Negative Multiple: -12.5
N/A N/A
US
P
PerkinElmer Inc
LSE:0KHE
1 327.9
5%
265.6
US
Thermo Fisher Scientific Inc
NYSE:TMO
24.6
6%
4.1
US
Danaher Corp
NYSE:DHR
25.2
5%
5
CH
Lonza Group AG
SIX:LONN
37.4
18%
2.1
US
Agilent Technologies Inc
NYSE:A
23.6
13%
1.8
US
IQVIA Holdings Inc
NYSE:IQV
15
8%
1.9
CN
WuXi AppTec Co Ltd
SSE:603259
20.6
30%
0.7
KR
Samsung Biologics Co Ltd
KRX:207940
16.9
20%
0.8
US
Mettler-Toledo International Inc
NYSE:MTD
25.3
4%
6.3
FR
Sartorius Stedim Biotech SA
PAR:DIM
27.7
19%
1.5